Incubation of cancer cells with CM from macrophages treated with zileuton, an inhibitor of ALOX5, a rate-limiting enzyme of 5-oxo-ETE biosynthesis, resulted in a noticeable reduction in the previously enhanced migration. Here, ALOX5 is linked to cancer.